About the 4th Annual CBPI ForumThe 4th Annual Sachs Cancer Bio Partnering & Investment Forum is designed to bring together thought leaders from cancer research institutes, patient advocacy groups, pharma and biotech to facilitate partnering and funding/investment. We expect around 250 delegates and around 30 company presentations by listed and private biotechnology companies seeking licensing & investment opportunities. Event's networking will be powered by online One-2-One meeting system and dedicated meeting facilities to make the event more transactional and productive.
Plenary Discussions Sessions include:
Confirmed Speakers & Chairs Include:
Presenting Opportunities:
Presenting at the forum offers excellent opportunities to showcase activities and highlight investment and partnership opportunities. Biotech companies will be able to communicate investment and licensing opportunities. These are for both public and private companies. The audience is comprised of financial and industry investors. These are streamed 10 or 20 minute presentations. Sachs forums are recognised as the leading international stage for those interested in investing in the biotech and life science industry and are highly transactional. They draw together an exciting cross-section of early-stage/pre-IPO, late-stage and public companies with leading investors, analysts, money managers and pharmas. The New York forum provides the additional interaction with the academic/scientific and patient advocacy communities. To view confirmed presenting companies for 2016 forum click HERE Sponsorship and Exhibition:
Sachs Associates has developed an extensive knowledge of the key individuals operating within the European and global biotech industry. This together with a growing reputation for excellence puts Sachs Associates at the forefront of the industry and provides a powerful tool by which to increase the position of your company in this market. Raise your company’s profile directly with your potential clients. All of our sponsorship packages are tailor made to each client, allowing your organisation to gain the most out of attending our industry driven events. To learn more about presenting, exhibition or sponsorship opportunities, please contact: Silvia Kar on + 44 (0)203 463 4890 or by email: Silvia. For full information about the last year's forum click HERE |
Silver Sponsor:
Supported by:
Pharma Licensing Groups
Attending in 2016: Financial/Advisory/
Investors Attending in 2016 Include: 203 Investment Partners A C Binder Corp. Advent Healthcare Ventures Aisling Capital, LLC Altius Strategy Consulting APS International Arcus Ventures Athyrium Capital Management Barracuda Finance LLC BTIG, LLC CBT Advisors CornerstoneCapital AG Cowen and Company Dabar Investment Associates Defined Health EcoR1 Capital, LLC Enso Ventures Excellentia Global Partners F1BioVentures FBR & Co. Flagship Ventures Gabelli & Company Griffin Securities JP Morgan Katan Associates, Inc. Ladenburg Thalmann Landmark Angels, Inc. Lexington Capital Management Little Gem Life Sciences Livingston Securities Loncar Investment, LLC LSWorks LLC MayTech Capital Management MedImmune Ventures, Inc. Mediqventures Mehta Partners, LLC MPM Capital MSF Capital Advisors Network 1 Financial Securities, Inc. Noble Life Science Partners NovaSecta Ltd. NSIP LLC Oppenheimer & Co., Inc. Park Avenue Capital Piper Jaffray & Co QVT Financial LP RA Capital Management Raymond James Financial, Inc. Remiges Ventures Rockport Venture Partners Roth Capital Partners, LLC Sternberg Investments SugarCone Biotech, LLC The Astrologers Fund Thomson Reuters UBS Versant Ventures Vinart Corp. Capital Management
|
ABOUT | REGISTRATION | Agenda
SPEAKERS| ATTENDEES | One-2-One | PRESENTERS
SPONSORS | SUPPORTERS | VENUE | ACCOMMODATION
Sachs Associates Switzerland AG
|
Sachs Associates Ltd.
|
T: +44 203 463 4890
E: SachsTeam@SachsForum.com
© COPYRIGHT 2023. ALL RIGHTS RESERVED.